Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate
Authors:
- 1 January 1991
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (2) , 150-151
Abstract
Acetazolamide, 500 mg 6 hourly, has been used to alkalinise the urine in patients receiving high dose methotrexate. A urinary pH of >7.5 was achieved in every cycle (13 cycles in 10 patients). In 6 cycles a single supplementary dose of sodium bicarbonate was necessary. Plasma methotrexate levels fell satisfactorily at 24 and 48 h. Acetazolamide is a simple and effective method of achieving urinary alkalinisation with advantages over oral and intravenous bicarbonate.Keywords
This publication has 7 references indexed in Scilit:
- Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tractThe Lancet, 1990
- Severe renal toxicity due to intermediate-dose methotrexateCancer Chemotherapy and Pharmacology, 1989
- The Role of Methotrexate in OsteosarcomaJNCI: Journal of the National Cancer Institute, 1988
- The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patientsCancer, 1988
- The use of diamox in the sequential methotrexate—5-fluorouracil therapy of advanced gastrointestinal cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell LymphomaAnnals of Internal Medicine, 1985
- Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.1977